1. Arthur Bloom Haemophilia Centre, Institute of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom;
2. Hemostasis and Thrombosis Center, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA;
3. Haemophilia R&D Portfolio, Novo Nordisk A/S, Soeborg, Denmark;
4. Haemophilia Centre, National Blood Centre, Kuala Lumpur, Malaysia;
5. Division of Hematology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand;
6. Haemophilia Clinical Operations, Novo Nordisk A/S, Soeborg, Denmark;
7. Gazi University Medical School, Ankara, Turkey;
8. Haemophilia Comprehensive Care Centre, Faculty of Health Sciences, National Health Laboratory Services and University of the Witwatersrand, Johannesburg, South Africa;
9. Department of Transfusion Medicine, Nagoya University Hospital, Nagoya, Japan;
10. Van Creveldkliniek, University Medical Centre, Utrecht, The Netherlands;
11. Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Bonn, Germany;
12. Division of Hematology and Medical Oncology, Mount Sinai Medical Center, New York, NY; and
13. Hôpital Edouard Herriot, University Claude Bernard Lyon 1, Lyon, France